bvrs-gamvac-combi
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 30, 2019 (NCT04130594)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Middle East respiratory syndrome-related coronavirusImmunity, active
Middle East respiratory syndrome-related coronavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04128059 | Phase 1/Phase 2 (Phase 2) | Oct 30, 2019 | Acellena Contract Drug Research and Development, Bessalar Clinic, Government of Russia |
| NCT04130594 | Phase 1/Phase 2 (Phase 2) | Oct 30, 2019 | Government of Russia |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Russia | Government | 2 | 2 | 1 | 2019 |
| Acellena Contract Drug Research and Development | For profit | 1 | 0 | 1 | 2019 |
| Bessalar Clinic | Academic/Hospital | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1